| Werner, Birgit (UgiSense AG 201604– Exec Board Member) |
Board member, executive |
UgiSense AG |
Germany |
| Werner, Dominik (Lonza 201610 Head Corporate Communications) |
Public Relations Manager / Investor Relations Manager |
Lonza (Group) |
Switzerland |
| Werner, Gregory (BIOCIUS 201005– EU Sales Manager) |
Sales Manager / Marketing Manager |
Agilent (Group) |
Switzerland |
| Werner, Jochen A. (Univ Essen 201805 Medical Director + CEO at Univ Hospital Essen) |
n. a. |
University of Duisburg-Essen |
Germany |
| Werner, Rolf G. (Univ Tübingen 201504 Professor of Industrial Biotechnology before Boehringer Ingelheim) |
Professor |
University of Tübingen (Eberhard-Karls-Universität) |
Germany |
| Werner, Thomas (Board Member of several companies before GSK SVP) |
Board member, non-executive |
GlaxoSmithKline (GSK) (Group) |
United Kingdom (GB) |
| Werner, Thomas (Genomatix 200609 CEO + CSO) |
Chief Executive Officer (CEO) |
Genomatix Software (Group) |
Germany |
| Werner, Udo (Thuringia (govt) 201309– Managing Director of bm-t GmbH before CyBio AG + TechnoTrend + McKinsey) |
Managing Director |
Thuringia (govt region) |
Germany |
| Wernet, Peter |
n. a. |
University of Düsseldorf |
Germany |
| Wesche, Holger (Harpoon Therapeutics 201810– CSO joined 2015 before Amgen + Tularik) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Harpoon Therapeutics Inc. (Nasdaq: HARP) |
United States (USA) |
| Weseloh, Rüdiger |
n. a. |
Sal. Oppenheim (Group) |
Germany |
| Wesnigk, Johanna B. (EMPA Bremen 201205) |
n. a. |
Environmental & Marine Project Management Agency Dr. Johanna B. Wesnigk (EMPA Bremen) |
Germany |
| Wessel, Rainer (DKFZ 201906– before CI3 Cluster Manager before Ganymed CEO) |
Cluster Manager |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wessjohann, Ludger (Modified Nature Company GmbH 201102 Managing Director) |
Managing Director |
Modified Nature Company GmbH |
Germany |
| West, Stuart (Biocatalysts Ltd 201803 Managing Director) |
Managing Director |
BRAIN (Group) |
United Kingdom (GB) |
| Westermann, Frank (mySugr 201706 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
Austria |
| Westermann, Stephan (Bruker 201202– EVP Order Execution, Production + Logistics of Bruker Scientific Instruments) |
Production Manager |
Bruker (Group) |
United States (USA) |
| Westhagemann, Michael (Hamburg (govt) 202010 Senator for Economics) |
Minister |
Hamburg (govt region) |
Germany |
| Westphal, Thomas (Glawe Delfs Moll 200809 Hamburg) |
n. a. |
Glawe Delfs Moll (Hamburg) |
Germany |
| Wetekam, Volker (General Electric 201205– CEO + President of GE Healthcare Germany before AGFA HealthCare + Siemens) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United Kingdom (GB) |
| Wetzel, Andrea (AW-Biotech-Marketing 201109) |
Consultant (economic/technology) |
AW-Biotech-Marketing – Dr. Andrea Wetzel |
Germany |
| Weyand, Michael (AmbAgon Technology 200810) |
n. a. |
AmbAgon Technology |
|
| Weyand, Stepa (Vendus 201303 Head of division Vendus Business Partner) |
President/Director/Head Business Group/Unit/Division |
Vendus (Group) |
Germany |
| Weyrauch, Kerstin (Zytomed Systems 200912 Managing Director) |
Managing Director |
Zytomed Systems GmbH |
Germany |
| Weß, Ludger (akampion before 2001–2006 BioCentury Senior Editor before Financial Times Deutschland) |
Public Relations Manager / Investor Relations Manager |
Akampion |
Germany |
| Weßling, Martina (Nordrhein-Westfalen (govt) 201707 BIO.NRW) |
Cluster Manager |
Nordrhein-Westfalen (govt region) |
Germany |
| Whalen, Christopher (Bruker Corp 201806 Director Global SPR Sales before Sierra Sensors Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
| Wheeler, Cameron (Cam) (Deerfield Management 201604 Prinicpal) |
Principal (venture capital) |
Deerfield (Group) |
United States (USA) |
| Wheeler, Patrick (ACD/Labs 201408 NMR Product Manager) |
Product Manager (personnel) |
Advanced Chemistry Development (ACD/Labs) (Group) |
Canada |
| Whelan, Kate (Notch Communications 201108 COO) |
Chief Executive Officer (CEO) |
Notch Communications AB |
Sweden |
| Whitaker, Paul (Biosilta 201604 Managing Director) |
Managing Director |
BioSilta (Group) |
United Kingdom (GB) |
| White, Brian (Deutsche Bank 200602 Analyst) |
Research Analyst |
Deutsche Bank (Group) |
Germany |
| White, James R. (Active Spectrum 201612 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Bruker (Group) |
United States (USA) |
| Whitehead, Carlene (Danaher 201204 European MarCom Specialist at Molecular Devices UK) |
Public Relations Manager / Investor Relations Manager |
Danaher (Group) |
United Kingdom (GB) |
| Whitmore, Jason D. (BY Capital 201509– Managing Director) |
Managing Director |
BY Capital (BlueYard Capital) (Group) |
Germany |
| Whitson, Todd (Karius 201706– CCO before CareDx + Ariosa Diagnostics + Genzyme Genetics) |
Chief Commercial Officer (CCO) |
Karius Inc. |
United States (USA) |
| Wibbelmann, Jobst (Wuesthoff & Wuesthoff 200809 Munich) |
n. a. |
Wuesthoff & Wuesthoff Patent- und Rechtsanwälte (Munich) |
Germany |
| Wichert, Burkhard (Baxter 201302 Managing Director of Baxter Oncology GmbH) |
Managing Director |
Baxter (Group) |
Germany |
| Wichert, Sven (Systasy Bioscience GmbH 201405 Managing Director + Co-Founder) |
Managing Director |
Systasy Bioscience GmbH |
Germany |
| Wick, Wolfgang (Univ Heidelberg 201410 Professor + Chair of Neurology Clinic) |
Professor |
University of Heidelberg (Ruperto Carola) |
Germany |
| Wicke, Ilka (Boehringer 201203 Director at Boehringer Ingelheim Venture Fund) |
Investment Manager |
Boehringer Ingelheim Venture Fund (BIVF) |
Germany |
| Wicki, Andreas (HBM Healthcare Investments 201402 CEO) |
Chief Executive Officer (CEO) |
HBM (Group) |
Switzerland |
| Wicklandt, Petra (Merck (DE) 201801– Head of newly created Corporate Affairs unit joined Merck 1994) |
Business Manager |
Merck (DE) (Group) |
Germany |
| Wicks, Frank (SAFC 200610 President) |
n. a. |
Merck (DE) (Group) |
United States (USA) |
| Widdowson, Caroline (Schauenburg 201412 promoted Produt Marketing Manager Thermal Desorption at Markes) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Widmann, Rudolf (AOP Orphan Pharmaceuticals AG 201110 CEO) |
Chief Executive Officer (CEO) |
Élan (Group) |
Austria |
| Widmann, Thomas |
n. a. |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
| Wiech, Hans (Camoleon Knowledge Brokerage 201108) |
n. a. |
|
|
| Wiechmann, Volker (Medways e. V. 201112 Managing Director) |
Managing Director |
Medways e. V. |
Germany |
| Wiedemann, Sonja (Eurofins 201801 Managing Director at Eurofins Genomics GmbH) |
Managing Director |
Eurofins (Group) |
Germany |
| Wiedey, Klaus (Manipal 201403 Managing Director of Ecron Acunova GmbH) |
Managing Director |
Manipal (Group) |
Germany |
| Wiedow, Oliver (Proteo Biotech 201411 Director of Proteo Inc) |
President/Director/Head Business Group/Unit/Division |
Proteo Biotech (Group) |
United States (USA) |
| Wiegeler, Nikola (Immatics 201708 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Immatics (Group) |
Germany |
| Wiegman, Al (Fresenius 201911 Head of Ventures at FMCV) |
Investment Manager |
Fresenius (Group) |
Germany |
| Wiehler, Klaus (Sierra Sensors 201010 Managing Director) |
Managing Director |
Bruker (Group) |
Germany |
| Wieland, Robert (Wieland Capital 201811 Managing Partner before CSFB + DLJ + Bayer) |
Managing Partner (investment firm) |
Wieland Capital GmbH & Co. KG |
Germany |
| Wieloch, Peter (Ingenium Medical Diagnostics 202012 Managing Director + Co-Founder) |
Managing Director |
Ingenium Digital Diagnostics GmbH |
Germany |
| Wienhold, Daniel (Deutsche Bank 201701 Head of Expert Team Life Sciences joined 200808 before IDT Biologika) |
n. a. |
Deutsche Bank (Group) |
Germany |
| Wieschaus, Eric (European Molecular Biology Laboratory, 201503) |
n. a. |
EMBL (European Molecular Biology Laboratory) |
Germany |
| Wiese, Hanns-Peter (Global Life Science Ventures 201105 Managing Director) |
Managing Director |
Global Life Science Ventures (Group) |
Germany |
| Wiesel, Philippe (AgomAb Therapeutics 202103– CMO before Genkyotex + Serono in US + CH) |
Chief Medical Officer (CMO) |
Genkyotex (Group) |
Switzerland |
| Wieser, Jochen (Optimare 201003 Dept of Science) |
Researcher (industry) |
Aerodata (Group) |
Germany |
| Wiesmüller, Karl-Heinz (EMC microcollections CEO) |
Chief Executive Officer (CEO) |
EMC microcollections GmbH |
Germany |
| Wiessner, Christoph (Asceneuron 201509 COO) |
Chief Operating Officer (COO) |
Asceneuron S.A. |
Switzerland |
| Wiest, Christian (iThera Medical 201110 Managing Director) |
Managing Director |
iThera Medical GmbH |
Germany |
| Wiest, Joachim (Cellasys GmbH 201201 Managing Director) |
Managing Director |
Cellasys GmbH |
Germany |
| Wiestler, Otmar D. (Helmholtz 201211 Head of DKFZ) |
President/Director/Head Business Group/Unit/Division |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Wigerinck, Piet (Galapagos 201304 CSO before SVP Developm before Tibotec) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Galapagos (Group) |
Belgium |
| Wiggins, Dale (Philips 201810 Business Leader HealthSuite Digital Platform) |
Product Manager (personnel) |
Philips (Group) |
Netherlands |
| Wijn, Annemieke |
n. a. |
Kraft Foods (Group) |
Germany |
| Wiklund, Jesper P. (Index Pharmaceuticals 201109– CEO before Sobi before Affectis + Evotec OAI + DeveloGen + Elan) |
Chief Executive Officer (CEO) |
InDex Pharmaceuticals (Group) |
Sweden |
| Wilbur, Christina (Roche 201603– Head of Global Human Resources + Member of Corp Executive Committe joined Roche 2002) |
Human Resources Manager |
Roche (Group) |
Switzerland |
| Wilcke, Ulf |
n. a. |
Sparkassen-Finanzgruppe (DE) [FICTIVE UNIT, NOT OFFICIAL GROUP!] (Group) |
Germany |
| Wilckens, Thomas (InnVentis 201409) |
n. a. |
InnVentis Ltd. |
Germany |
| Wild, Anthony H. (Bows Pharmaceuticals AG 200610– General Partner before MedPointe Pharma CEO before Warner-Lambert) |
General Partner (venture partner) |
Bows Pharmaceuticals AG |
Switzerland |
| Wild, Hanno (Bayer 201312 SVP + Head Candidate Generation + Exploration at Bayer HealthCare Global Drug Discovery) |
Research & Development Manager |
Bayer (Group) |
Germany |
| Wild, Hans-Peter (Wild Group 201509 Owner + Chairman) |
Board member |
Wild Group (Group) |
|
| Wildanger, Oliver (Genetics Company 200512) |
n. a. |
Genetics Company Inc., The |
Switzerland |
| Wilde, Lars Christian (Compass Pathways 202004 CBO + Co-Founder) |
Chief Business Officer (CBO) |
Compass Pathways (Group) |
United Kingdom (GB) |
| Wilhelm, Andreas (Tecan 2012 promoted General Counsel + Management Board Member before Head Legal Affairs) |
General Counsel / Chief Legal Officer (CLO) |
Tecan (Group) |
Switzerland |
| Wilhelm, Olaf Georg (Therawis 201405– Managing Director before Wilex 2001–201403 CEO) |
Chief Executive Officer (CEO) |
Therawis (Group) |
Germany |
| Wilhelmsson, Claes |
Investment Manager |
Investor AB (Wallenberg) (Group) |
Sweden |
| Wilkens, Jochen (Chemie Nord 201010 Managing Director) |
Managing Director |
Chemie Nord – Arbeitgeberverband für die Chemische Industrie in Norddeutschland e. V. |
Germany |
| Wilkinson, Malcolm (Kirkstall 201802 CEO) |
Chief Executive Officer (CEO) |
Kirkstall (GB) |
United Kingdom (GB) |
| Wilkinson, Michael (MiniFAB 201906 Executive Director + acting CEO) |
Chief Executive Officer (CEO) |
Schott (Group) |
Australia |
| Wilks, Chris (Sonic Healthcare 201701 CFO + Finance Director) |
Chief Financial Officer (CFO) |
Sonic Healthcare (Group) |
Australia |
| Willems, Frank (NonWoTecc Medical 201107 Managing Director) |
Managing Director |
NonWoTecc Medical GmbH |
Germany |
| Williams, Antony (RSC 200905– VP Strategic Development before ChemZoo 200804 President) |
n. a. |
Royal Society of Chemistry, The (RSC) |
United Kingdom (GB) |
| Williams, David (Nanna Therapeutics 202004 CEO before Discuva) |
Chief Executive Officer (CEO) |
Astellas (Group) |
United Kingdom (GB) |
| Williams, James (Siemens 201304 CEO of Siemens Molecular Imaging business unit) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| WIlliams, Jeff (Clinipace 201504 CEO) |
Chief Executive Officer (CEO) |
Clinipace (Group) |
United States (USA) |
| Williams, Jeff (NeuMoDx 201809 CEO) |
Chief Executive Officer (CEO) |
NeuMoDx Moleuclar Inc. |
United States (USA) |
| Williams, Jon (Aquapharm Biodiscovery 201207 VP Commercial) |
Chief Commercial Officer (CCO) |
Aquapharm Biodiscovery Ltd. |
United Kingdom (GB) |
| Williams, Lewis T. (Five Prime –200910– Founder + Executive Chairman) |
Company Founder |
Five Prime Therapeutics, Inc. (Nasdaq: FPRX) (FivePrime) |
United States (USA) |
| Willinger, Peter (Apogenix 201506– CFO before Sygnis Pharma + Lion Bioscience) |
Chief Financial Officer (CFO) |
Apogenix AG |
Germany |
| Willinger, Thomas R. (ZFHN Zukunftsfonds Heilbronn 201105 Managing Director) |
Managing Director |
Zukunftsfonds Heilbronn (Group) |
Germany |
| Willinsky, Brian (PerkinElmer 201403) |
Public Relations Manager / Investor Relations Manager |
PerkinElmer (Group) |
United States (USA) |
| Willkommen, Hannelore (NewLab BioQuality 200504– VP Regulatory Affairs before Clearant before Paul Ehrlich Institute) |
Regulatory Affairs Manager |
Charles River (Group) |
Germany |
| Willmitzer, Lothar (Max Planck 201006 Managing Director MPI for Molecular Plant Physiology) |
President/Director/Head of Research Organisation/Unit |
Max Planck Society for the Advancement of Science |
Germany |
| Willms, Andrea (Norgenta 200602) |
n. a. |
Hamburg (govt region) |
Germany |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 72 73 74 75 
![Picture [iito] Made Without Love 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-made-without-love.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
